According to the FDA’s website, the following state of the propofol injection shortage is as follows:
- Teva Pharmaceuticals has recently released some propofol 20-mL, 50-mL and 100-mL vials and expects additional quantities over the coming months.
- Hospira Pharmaceuticals has released some propofol 20-mL, 50-mL and 100-mL and expects additional quantities in the coming months.
- APP has increased production in response to the increased demand as well as received approval to release imported Fresenius Propoven 1%.
The FDA’s new website on the propofol shortage is available here.
Read the ASA’s release on the propofol shortage.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
